Diagnostic ultrasound combined with glycoprotein IIb/IIIa-targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions

Circulation

Volumn 119, Issue 10, 2009, Pages 1378-1385

  Xie, Feng ^c   Lof, John ^c   Matsunaga, Terry ^a   Zutshi, Reena ^b   Porter, Thomas R ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b ImaRx Therapeutics Inc   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Coronary disease; Microbubbles; Thrombolysis; Ultrasonics

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR; HEPARIN; SARUPLASE; RECOMBINANT PROTEIN; UROKINASE;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE TENSION; MICROBUBBLE; NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RECANALIZATION; ST SEGMENT ELEVATION; SWINE; ULTRASOUND; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; ECHOGRAPHY; ELECTROCARDIOGRAPHY; HEART MUSCLE REPERFUSION; HEMODYNAMICS; INSTRUMENTATION; METHODOLOGY; MICROCIRCULATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOGRAPHY; RANDOMIZATION; ULTRASOUND THERAPY;

ANIMALS; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; HEMODYNAMICS; MICROBUBBLES; MICROCIRCULATION; MYOCARDIAL REPERFUSION; MYOCARDIUM; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SUS SCROFA; ULTRASONIC THERAPY; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 64549085429     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.825067     Document Type: Article

References (39)

1. Waxman S, Mittleman MA, Zarich SW, Fitzpatrick PJ, Lewis SM, Leeman DE, Shubrooks SJ Jr, Snyder JT, Muller JE, Nesto RW. Angio- scopic assessment of coronary lesions underlying thrombus. Am J Cardiol. 1997;79:1106-1109.
2. Ueda Y, Asakura M, Hirayama A, Komamura K, Hori M, Komada K. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction: serial angioscopic observations. J Am Coll Cardiol. 1996;27:606-610.
3. Thieme T, Wernecke KD, Meyer R, Brandenstein E, Habedank D, Hinz A, Felix SB, Baumann G, Kleber FX. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol. 1996; 28:1-6.
4. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet. 1988;1:545-549.
5. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction:ISIS-2. Lancet. 1988;2:349-360.
6. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
7. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588-636.
8. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983;309:1477-1482.
9. Goldenberg I, Matetzky S, Halkin A, Roth A, Di Segni E, Freimark D, Elian D, Agranat O, Har Zahav Y, Guetta V, Hod H. Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2003;145:862-867.
10. Jong P, Cohen EA, Batchelor W, Lazzam C, Kreatsoulas C, Natarajan MK, Strauss BH. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction. Am Heart J. 2001;141:218 -225.
11. Bolli R, Triana JF; Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischemia: evidence for microvascular "stunning." Circ Res. 1990;67:332-343.
12. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.
13. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 2001;38:1283-1294.
14. Novelty R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Possum AC. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiog- raphy, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol. 2008;52:181-189.
15. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation. 1995;92:1148 -1150.
16. Porter TR, Leveen RF, Fox R, Kricsfeld A, Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J. 1996;132:964-968.
17. Dhond MR, Nguyen TT, Dolan C, Pulido G, Bommer WJ. Ultrasound-enhanced thrombolysis at 20 KHz with air-filled and perfluorocarbon- filled contrast biospheres. J Am Soc Echocardiogr. 2000;13:1025-1029.
18. Xie F, Tsutsui JM, Lof J, Unger EC, Johanning J, Culp WC, Matsunaga T, Porter TR. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol. 2005;31:979 -985.
19. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado- Mederos R, Arenillas JF, Huertas R, Purroy F, Delgado P, Alvarez-Sabin J. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006;37:425-429.
20. Tiukinhoy-Laing SD, Huang S, Klegerman M, Holland CK, McPherson DD. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res. 2007;119:777-784.
21. Birnbaum Y, Luo H, Nagai T, Fishbein MC, Peterson TM, Li S, Kricsfeld D, Porter TR, Siegel RJ. Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of micro-bubbles. Circulation. 1998;97:130-134.
22. Nishioka T, Luo H, Fishbein MC, Cercek B, Forrester JS, Kim CJ, Berglund H, Siegel RJ. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study. J Am Coll Cardiol. 1997;30:561-568.
23. Tsutsui JM, Xie F, Johanning J, Lof J, Cory B, Thomas L, Matsunaga T, Unger E, Porter TR. Treatment of deeply located acute intravascular thrombi with low frequency guided ultrasound and intravenous micro-bubbles. J Ultrasound Med. 2006;25:1161-1168.
24. Xie F, Everbach C, Matsunaga T, Lof J, He A, Bennett RM, Porter TR. Detection of intravascular cavitational activity during treatment of deep vessel thromboses with diagnostic ultrasound and intravenous micro- bubbles. Circulation. 2007;116(suppl):II-646.
25. Porter TR, Kricsfeld D, Lof J, Everbach EC, Xie F. Effectiveness of transcranial and transthoracic ultrasound and microbubbles in dissolving intravascular thrombi. J Ultrasound Med. 2001;20:1313-1325.
26. Coggins MP, Sklenar J, Le DE, Wei K, Lindner JR, Kaul S. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation. 2001;104:2471-2477.
27. Culp WC, Porter TR, Xie F, Goertzen TC, McCowan TC, Vonk BN, Baxter BT. Microbubble potentiated ultrasound as a method of declotting thrombosed dialysis grafts: experimental study in dogs. Cardiovasc Intervent Radiol. 2001;24:407-412.
28. Culp WC, Porter TR, McCowan TC, Roberson PK, James CA, Matchett WJ, Moursi M. Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Intervent Radiol. 2003;14:343-347.
29. Porter TR, Everbach C, Kricsfeld D, Xie F. Myocardial cavitational activity during continuous infusion and bolus intravenous injections of perfluorocarbon-containing microbubbles. J Am Soc Echocardiogr. 2001; 14:618-625.
30. Miller DL. Particle gathering and microstreaming near ultrasonically activated gas-filled micropores. J Acoust Soc Am. 1988;84:1378-1387.
31. Datta S, Coussios C-C, McAdory LE, Tan J, Porter T, De Courten-Myers G, Holland C. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol. 2006;32:1257-1267.
32. Sakuma T, Leong-Poi H, Fisher NG, Goodman NC, Kaul S. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. JAmSoc Echocardiogr. 2003;16:15-21.
33. Thillmanns H, Leinberger H, Neumann FJ, Steinhausen M, Parekh N, Zimmerman R, Dussel R, Kuebler W. Myocardial microcirculation in the beating heart: in vivo microscopic studies. In: Spaan JAE, Bruscheke AVG, Gittenberger-de Groot AC, eds. Coronary Circulation. Dordrecht, Netherlands: Martin Nijhoff Publishers; 1987;88-94.
34. Feldman LJ, Coste P, Furber A, Dupouy P, Slama MS, Monassier JP, Tron C, Lafont A, Faraggi M, Le Guludec D, Dubois-Rande JL, Steg PG; FRench Optimal STenting-2 Investigators. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation. 2003;107:2684-2689.
35. Siegel RJ, Suchkova VN, Miyamoto T, Luo H, Baggs RB, Neuman Y, Horzewski M, Suorsa V, Kobal S, Thompson T, Echt D, Francis CW. Ultrasound energy improves myocardial perfusion in the presence of coronary occlusion. J Am Coll Cardiol. 2004;44:1454-1458.
36. Lee CW, Park SW, Cho GY, Hong MK, Kim JJ, Kang DH, Song JK, Lee HJ, Park SJ. Pressure-derived fractional collateral flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction. J Am Coll Cardiol. 2000;15:949-955.
37. Leng Tong K, Kaul S, Wang X, Rinkevich D, Kalvaitis S, Belcik T, Lepper W, Foster WA, Wei K. Myocardial contrast echocardiography versus thrombolysis in myocardial infarction score in patients presenting to the emergency department with chest pain and a non-diagnostic electrocardiogram. J Am Coll Cardiol. 2005;46:920-927.
38. Gawaz M, Neumann FJ, Dickfeld T, Reininger A, Adelsberger H, Gebhardt A, Schömig A. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation. 1997;96: 1809-1818.
39. Santoro GM, Valenti R, Buonamici P, Bolognese L, Cerisano G, Moschi G, Trapani M, Antoniucci D, Fazzini PF. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echo- cardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol. 1998;82:932-937.